StockWatch
·

KMC SPECIALITY HOSPITALS (INDIA) LTD. Q2 FY27 Results

KMCSHILQ2 FY27 Results
Filing
Result:Very Good· Market: Crashed#Margin expansion
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue92.941.3%24.1%
Total Income94.390.9%24.0%
Expenditure72.762.3%18.5%
PBT21.643.6%46.8%
Net Profit16.222.1%49.6%
OPM30.45%0.59pp2.62pp
NPM17.19%0.52pp2.95pp
EPS0.992.9%50.0%
View full financials

Revenue +24.1% YoY and PAT +49.6% YoY with genuine margin expansion (NPM 14.2%→17.2%, OPM 27.8%→30.5%) and no one-off items make this a clean, core-business-driven standout for a hospital, even as sequential growth cooled from Q1's exceptional pace.

Q2 FY-2027 RESULTS · KMCSHIL

KMC Speciality: standalone PAT up 49.6% YoY to ₹16.2 Cr on margin gains, QoQ growth cools

PAT +49.64% YoY · revenue +24.08% · margins expanding

13 Nov 2026 · 3 min read
Revenue

₹92.94 Cr

+24.08% YoY

PAT (standalone)

₹16.22 Cr

+49.64% YoY

Net margin

17.18%

+2.9pp YoY

EPS

₹0.99

KMC Speciality Hospitals' standalone Q2 FY27 (quarter ended September 30, 2026) print is the test our pre-result preview flagged: whether the company could hold Q1's exceptional pace into a seasonally softer quarter. Revenue from operations came in at ₹92.94 Cr, up 24.1% YoY from ₹74.90 Cr, but only 1.3% above Q1 FY27's ₹91.78 Cr — effectively flat sequentially. Standalone PAT rose 49.6% YoY to ₹16.22 Cr (from ₹10.84 Cr) but slipped 2.1% QoQ from ₹16.57 Cr. That confirms the sequential cooling the preview was watching for, rather than a repeat of Q1's 120% YoY PAT surge.

The scoreboard

Q2 FY-2027 vs prior quarters

Standalone P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹92.94 Cr+1.3%+24.1%
Expenses₹72.76 Cr+2.3%+18.5%
PAT₹16.22 Cr-2.11%+49.64%
Net margin17.18%-0.5pp+2.9pp
EPS₹0.99-2.9%+50%

The YoY margin expansion is real: net profit margin (PAT/total income) widened to 17.19% from 14.24% a year ago, and the EBITDA-level operating margin improved to roughly 30.5% from ~27.8%, as employee costs and other overheads grew slower than revenue while finance costs (₹1.93 Cr) and depreciation (₹6.19 Cr) stayed broadly flat YoY. Against Q1 FY27, though, NPM (17.71%) and OPM (~31.0%) were both marginally higher, so the quarter gave back a sliver of the margin gain rather than extending it. No exceptional items are disclosed in the statement or notes, so the 49.6% YoY PAT growth is also the clean, adjusted figure.

₹
108.55129.22149.89170.55191.22171.908-1009-0109-2410-1911-1111-13Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹171.9, up 5.8% over the past month of trading.

₹ Cr
06.1912.3718.564.52Q4 FY25rev ₹61 Cr7.54Q1 FY26rev ₹67 Cr10.84Q2 FY26rev ₹75 Cr13.73Q3 FY26rev ₹82 Cr16.57Q1 FY27rev ₹92 Cr16.22Q2 FY27rev ₹93 Cr
Quarterly standalone PAT, ₹ Crore

For context: revenue is at a 6-quarter high.

Beyond the headline

What the summary numbers don't show

EPS (basic, not annualised) ₹0.99 vs ₹0.66 YoY and ₹1.02 in Q1 FY27

Tax expense ₹5.42 Cr on PBT of ₹21.64 Cr (effective rate ~25%), up 46.8% YoY

Against our preview's expected ₹95–100 Cr revenue band, the ₹92.94 Cr print lands just below range, while the 17.19% NPM sits inside the flagged 16–18% band. The filing discloses neither occupancy nor ARPOB, so those two preview watch items — 84–88% occupancy and ₹32,500–33,500 ARPOB — remain unresolved this quarter. There is no formal sell-side consensus tracking KMCSHIL (confirmed via search), so vsStreet is unknown, and management has issued no prior guidance or outlook on record either; no management press release accompanies this filing beyond the board-meeting outcome letter, so there is no additional management commentary to reconcile against the numbers. The quarter's other filings — a 5.37% promoter share encumbrance and SEBI takeover-code disclosures (Sep 15, Oct 14), plus a trading-window closure (Sep 29) ahead of results — are procedural and carry no direct read on the operating numbers. Capital work-in-progress rose to ₹23.40 Cr from ₹12.34 Cr at FY26-end, consistent with the ₹519 Cr expansion plan referenced in the preview, while cash and equivalents closed the half at ₹82.62 Cr.

  • W1

    Whether Q3 FY27 revenue breaks above the ₹92.94 Cr base after two quarters of near-flat sequential growth

  • W2

    Occupancy and ARPOB disclosure — not reported this quarter; preview's 84-88% occupancy and ₹32,500-33,500 ARPOB bands remain unverified

  • W3

    Margin trajectory — NPM/OPM both ticked down QoQ (17.19% vs 17.71%; ~30.5% vs ~31.0%) after YoY expansion; watch if this reverses or persists

Informational and educational content only. Not investment advice.